<?xml version="1.0" encoding="UTF-8"?>
<project>
  <language>en</language>
  <availableLanguages>en</availableLanguages>
  <rcn>252999</rcn>
  <id>101114473</id>
  <acronym>RespirOndine</acronym>
  <teaser>AtmosR is a start-up whose mission is to develop innovative therapeutic solutions for patients suffering from severe and often fatal disorders of the central nervous system.Our company has established a technology in order to develop treatments for aggregate pathologies (such...</teaser>
  <objective>AtmosR is a start-up whose mission is to develop innovative therapeutic solutions for patients suffering from severe and often fatal disorders of the central nervous system.

Our company has established a technology in order to develop treatments for aggregate pathologies (such as ALS, Kennedy disease, Multisystem Atrophy, Parkinson, Huntington...) which represent a major health problem considering the high number of patients worldwide and the high unmet medical need. 

The first disorder targeted by AtmosR is Congenital Central Hypoventilation Syndrome (CCHS), a rare genetic syndrome which presents as its main symptom severe periods of hypoventilation. Patients are kept alive thanks to mechanical ventilation administered through a tracheostomy. Our goal is to develop a drug that will be life changing for patients and their families, liberating them from the machine, lifting the vital risk and allowing them to live independently.

Our team consists of multidisciplinary profiles with experience in both drug development, particularly in the field of rare diseases, and in business management. As a spin-off of the french CCHS patient organization, we work in close cooperation with the international academic experts in CCHS, especially in France, Italy and Israël. 

We have identified a Hit compound ATS-003 that is active in both in vitro and in vivo CCHS robust models and we have optimized the compound thanks to a chemistry program in order to improve its efficiency and lower its toxicity for a better long term use tolerance. We are starting regulatory preclinical work in 2023 with this new Lead compound and have planned the first clinical trials by mid 2025 and an early drug access for patients in 2027.

In addition to CCHS, we have identified  several disorders with similar protein aggregation mechanisms. We plan to test and develop our Lead compound for other more common disorders and the purpose of this project is to idententify the most promising one for our Lead.</objective>
  <title>Development of life changing drugs for patients suffering from severe and fatal neurological disorders</title>
  <totalCost>0</totalCost>
  <ecMaxContribution>75000</ecMaxContribution>
  <startDate>2023-07-01</startDate>
  <endDate>2023-12-31</endDate>
  <ecSignatureDate>2023-06-01</ecSignatureDate>
  <duration>6</duration>
  <status>CLOSED</status>
  <keywords>neurological, disorder, drug, treatment, innovation, life changing, transformativ</keywords>
  <identifiers>
    <grantDoi>10.3030/101114473</grantDoi>
  </identifiers>
  <validation>
    <euroSciVoc>false</euroSciVoc>
  </validation>
  <sourceUpdateDate>2023-06-05 21:54:34</sourceUpdateDate>
  <contentCreationDate>2023-07-11 15:43:39</contentCreationDate>
  <contentUpdateDate>2023-07-11 15:43:31</contentUpdateDate>
  <lastUpdateDate>2025-09-19 14:49:10</lastUpdateDate>
  <relations>
    <associations>
      <article source="editorial" type="relatedArticle">
        <availableLanguages>de,en,es,fr,it,pl</availableLanguages>
        <rcn>445848</rcn>
        <id>445848-life-changing-drug-development-for-neurological-disorders</id>
        <title>Life-changing drug development for neurological disorders</title>
        <contentUpdateDate>2023-12-28 15:50:27</contentUpdateDate>
        <relations>
          <categories>
            <category classification="collection" type="belongsTo">
              <language>en</language>
              <availableLanguages>de,en,es,fr,it,pl</availableLanguages>
              <code>/projectDescription</code>
              <title>Project description</title>
              <description>Article: description of linked project written by editorial team</description>
              <displayCode>/Project description</displayCode>
            </category>
            <category classification="source" type="isProvidedBy">
              <language>en</language>
              <availableLanguages>de,en,es,fr,it,pl</availableLanguages>
              <code>/editorial</code>
              <title>CORDIS Editorial</title>
              <description>Written by CORDIS</description>
              <displayCode>/CORDIS Editorial</displayCode>
            </category>
          </categories>
        </relations>
      </article>
      <call source="corda" type="relatedMasterCall">
        <rcn>55653</rcn>
        <title>HORIZON-EIE-2022-SCALEUP-02</title>
        <identifier>HORIZON-EIE-2022-SCALEUP-02</identifier>
      </call>
      <call source="corda" type="relatedSubCall">
        <rcn>55653</rcn>
        <title>HORIZON-EIE-2022-SCALEUP-02</title>
        <identifier>HORIZON-EIE-2022-SCALEUP-02</identifier>
      </call>
      <organization netEcContribution="75000" totalCost="0" source="corda" order="1" ecContribution="75000" terminated="false" sme="true" type="coordinator">
        <availableLanguages>en</availableLanguages>
        <rcn>1982151</rcn>
        <id>885997904</id>
        <vatNumber>FR68852793108</vatNumber>
        <legalName>ATMOSR</legalName>
        <address>
          <street>10 IMPASSE DES LOTIERS</street>
          <city>Fuveau</city>
          <postalCode>13710</postalCode>
          <country>FR</country>
          <geolocation>49.3668878,6.1093699</geolocation>
        </address>
        <relations>
          <categories>
            <category classification="organizationActivityType" type="relatedOrganizationActivityType">
              <language>en</language>
              <availableLanguages>de,en,es,fr,it,pl</availableLanguages>
              <code>/PRC</code>
              <title>Private for-profit entities (excluding Higher or Secondary Education Establishments)</title>
              <displayCode>/Private for-profit entities (excluding Higher or Secondary Education Establishments)</displayCode>
            </category>
          </categories>
          <regions>
            <region type="relatedNutsCode">
              <name>Bouches-du-Rhône</name>
              <rcn>1464091</rcn>
              <nutsCode>FRL04</nutsCode>
              <parents>
                <region>
                  <name>Provence-Alpes-Côte d’Azur</name>
                  <rcn>1464968</rcn>
                  <nutsCode>FRL0</nutsCode>
                  <parents>
                    <region>
                      <name>Provence-Alpes-Côte d’Azur</name>
                      <rcn>1464967</rcn>
                      <nutsCode>FRL</nutsCode>
                      <parents>
                        <region>
                          <name>France</name>
                          <rcn>258902568</rcn>
                          <nutsCode>FR</nutsCode>
                          <euCode>FR</euCode>
                          <isoCode>FR</isoCode>
                        </region>
                      </parents>
                    </region>
                  </parents>
                </region>
              </parents>
            </region>
            <region type="relatedRegion">
              <name>France</name>
              <rcn>258902568</rcn>
              <nutsCode>FR</nutsCode>
              <euCode>FR</euCode>
              <isoCode>FR</isoCode>
            </region>
          </regions>
        </relations>
      </organization>
      <programme type="relatedTopic" source="corda">
        <availableLanguages>en</availableLanguages>
        <rcn>706827</rcn>
        <id>HORIZON_HORIZON-EIE-2022-SCALEUP-02-02</id>
        <code>HORIZON-EIE-2022-SCALEUP-02-02</code>
        <frameworkProgramme>HORIZON</frameworkProgramme>
        <title>Women TechEU</title>
        <parent>
          <programme>
            <rcn>20300</rcn>
            <code>HORIZON-Topics</code>
          </programme>
        </parent>
        <relations>
          <categories>
            <category classification="collection" type="belongsTo">
              <language>en</language>
              <availableLanguages>de,en,es,fr,it,pl</availableLanguages>
              <code>/topic</code>
              <title>Topic</title>
              <description>Programme: Part of the Commission work programme implementing legal basis</description>
              <displayCode>/Topic</displayCode>
            </category>
            <category classification="source" type="isProvidedBy">
              <language>en</language>
              <availableLanguages>de,en,es,fr,it,pl</availableLanguages>
              <code>/corda</code>
              <title>CORDA</title>
              <description>RTD research data warehouse</description>
              <displayCode>/CORDA</displayCode>
            </category>
            <category classification="topicKeyword" type="isAbout">
              <language>en</language>
              <availableLanguages>en</availableLanguages>
              <code>/43454413</code>
              <title>Materials engineering</title>
              <displayCode>/Materials engineering</displayCode>
            </category>
            <category classification="topicKeyword" type="isAbout">
              <language>en</language>
              <availableLanguages>en</availableLanguages>
              <code>/43449921</code>
              <title>Biotechnology</title>
              <displayCode>/Biotechnology</displayCode>
            </category>
            <category classification="topicKeyword" type="isAbout">
              <language>en</language>
              <availableLanguages>en</availableLanguages>
              <code>/43451548</code>
              <title>Energy</title>
              <displayCode>/Energy</displayCode>
            </category>
            <category classification="topicKeyword" type="isAbout">
              <language>en</language>
              <availableLanguages>en</availableLanguages>
              <code>/42590846</code>
              <title>Innovation in the Culture and Audiovisual sectors</title>
              <displayCode>/Innovation in the Culture and Audiovisual sectors</displayCode>
            </category>
            <category classification="topicKeyword" type="isAbout">
              <language>en</language>
              <availableLanguages>en</availableLanguages>
              <code>/43452136</code>
              <title>Fintech (Financial technology)</title>
              <displayCode>/Fintech (Financial technology)</displayCode>
            </category>
            <category classification="topicKeyword" type="isAbout">
              <language>en</language>
              <availableLanguages>en</availableLanguages>
              <code>/43452211</code>
              <title>Food and beverages</title>
              <displayCode>/Food and beverages</displayCode>
            </category>
            <category classification="topicKeyword" type="isAbout">
              <language>en</language>
              <availableLanguages>en</availableLanguages>
              <code>/31101542</code>
              <title>Education</title>
              <displayCode>/Education</displayCode>
            </category>
            <category classification="topicKeyword" type="isAbout">
              <language>en</language>
              <availableLanguages>en</availableLanguages>
              <code>/43450173</code>
              <title>Chemical engineering</title>
              <displayCode>/Chemical engineering</displayCode>
            </category>
            <category classification="topicKeyword" type="isAbout">
              <language>en</language>
              <availableLanguages>en</availableLanguages>
              <code>/43453531</code>
              <title>Information and Communication Technology (ICT)</title>
              <displayCode>/Information and Communication Technology (ICT)</displayCode>
            </category>
            <category classification="topicKeyword" type="isAbout">
              <language>en</language>
              <availableLanguages>en</availableLanguages>
              <code>/31101546</code>
              <title>Engineering</title>
              <displayCode>/Engineering</displayCode>
            </category>
            <category classification="topicKeyword" type="isAbout">
              <language>en</language>
              <availableLanguages>en</availableLanguages>
              <code>/43451193</code>
              <title>Earth and related environmental sciences</title>
              <displayCode>/Earth and related environmental sciences</displayCode>
            </category>
            <category classification="topicKeyword" type="isAbout">
              <language>en</language>
              <availableLanguages>en</availableLanguages>
              <code>/31101580</code>
              <title>Health</title>
              <displayCode>/Health</displayCode>
            </category>
            <category classification="topicKeyword" type="isAbout">
              <language>en</language>
              <availableLanguages>en</availableLanguages>
              <code>/43454761</code>
              <title>Mobility and transportation</title>
              <displayCode>/Mobility and transportation</displayCode>
            </category>
            <category classification="topicKeyword" type="isAbout">
              <language>en</language>
              <availableLanguages>en</availableLanguages>
              <code>/43451374</code>
              <title>Electrical and electronic engineering</title>
              <displayCode>/Electrical and electronic engineering</displayCode>
            </category>
            <category classification="topicKeyword" type="isAbout">
              <language>en</language>
              <availableLanguages>en</availableLanguages>
              <code>/43449075</code>
              <title>Agriculture / Rural Development / Fisheries</title>
            </category>
            <category classification="topicKeyword" type="isAbout">
              <language>en</language>
              <availableLanguages>en</availableLanguages>
              <code>/43450656</code>
              <title>Consumer products and services</title>
              <displayCode>/Consumer products and services</displayCode>
            </category>
          </categories>
        </relations>
      </programme>
      <programme type="relatedLegalBasis" source="corda" uniqueProgrammePart="true">
        <availableLanguages>en</availableLanguages>
        <rcn>705796</rcn>
        <id>HORIZON.3.2</id>
        <code>HORIZON.3.2</code>
        <frameworkProgramme>HORIZON</frameworkProgramme>
        <pga>HORIZON.3.2</pga>
        <title>European innovation ecosystems</title>
        <parent>
          <programme>
            <rcn>705791</rcn>
            <code>HORIZON.3</code>
            <parent>
              <programme>
                <rcn>705725</rcn>
                <code>HORIZON</code>
              </programme>
            </parent>
          </programme>
        </parent>
        <relations>
          <categories>
            <category classification="collection" type="belongsTo">
              <language>en</language>
              <availableLanguages>de,en,es,fr,it,pl</availableLanguages>
              <code>/legalbasis</code>
              <title>Legal Basis</title>
              <description>Programme: Legal basis for research funding</description>
              <displayCode>/Legal Basis</displayCode>
            </category>
            <category classification="source" type="isProvidedBy">
              <language>en</language>
              <availableLanguages>de,en,es,fr,it,pl</availableLanguages>
              <code>/corda</code>
              <title>CORDA</title>
              <description>RTD research data warehouse</description>
              <displayCode>/CORDA</displayCode>
            </category>
          </categories>
        </relations>
      </programme>
      <result type="relatedResult" source="corda">
        <availableLanguages>en</availableLanguages>
        <rcn>1067035</rcn>
        <id>101114473_PSHORIZON</id>
        <title>Periodic Reporting for period 1 - RespirOndine (Development of life changing drugs for patients suffering from severe and fatal neurological disorders)</title>
        <description>periodic</description>
        <teaser>AtmosR is a start-up whose mission is to develop innovative therapeutic solutions for patients suffering from severe of the central nervous system and currently without solution.Our company has established a technology to develop treatments for protein aggregation disorders...</teaser>
        <sourceUpdateDate>2024-03-23 09:09:54</sourceUpdateDate>
        <contentUpdateDate>2024-03-26 14:16:00</contentUpdateDate>
        <relations>
          <associations>
            <webItem type="relatedResultAttachment" source="corda">
              <language>en</language>
              <availableLanguages>en,any</availableLanguages>
              <uri>/docs/results/horizon/101114/101114473_PS/photo-labo-atmosr.jpg</uri>
              <alternativeText>AtmosR team</alternativeText>
              <mimetype>image/jpeg</mimetype>
              <size>154624</size>
            </webItem>
          </associations>
          <categories>
            <category classification="collection" type="belongsTo">
              <language>en</language>
              <availableLanguages>de,en,es,fr,it,pl</availableLanguages>
              <code>/pubsum</code>
              <title>Report Summary</title>
              <description>Result: Publishable summary (FP7 SESAM) and Summary for publication (H2020 SyGMa)</description>
              <displayCode>/Report Summary</displayCode>
            </category>
            <category classification="source" type="isProvidedBy">
              <language>en</language>
              <availableLanguages>de,en,es,fr,it,pl</availableLanguages>
              <code>/corda</code>
              <title>CORDA</title>
              <description>RTD research data warehouse</description>
              <displayCode>/CORDA</displayCode>
            </category>
          </categories>
        </relations>
      </result>
    </associations>
    <categories>
      <category classification="collection" type="belongsTo">
        <language>en</language>
        <availableLanguages>de,en,es,fr,it,pl</availableLanguages>
        <code>/project</code>
        <title>Project</title>
        <description>Project factsheets</description>
        <displayCode>/Project</displayCode>
      </category>
      <category classification="euroSciVoc" type="isInFieldOfScience">
        <language>en</language>
        <availableLanguages>de,en,es,fr,it,pl</availableLanguages>
        <code>/23/49/327</code>
        <title>neurobiology</title>
        <displayCode>/natural sciences/biological sciences/neurobiology</displayCode>
      </category>
      <category classification="euroSciVoc" type="isInFieldOfScience">
        <language>en</language>
        <availableLanguages>de,en,es,fr,it,pl</availableLanguages>
        <code>/21/35/159/79909316</code>
        <title>drug discovery</title>
        <displayCode>/medical and health sciences/basic medicine/pharmacology and pharmacy/drug discovery</displayCode>
      </category>
      <category classification="euroSciVoc" type="isInFieldOfScience">
        <language>en</language>
        <availableLanguages>de,en,es,fr,it,pl</availableLanguages>
        <code>/21/35/145</code>
        <title>pathology</title>
        <displayCode>/medical and health sciences/basic medicine/pathology</displayCode>
      </category>
      <category classification="euroSciVoc" type="isInFieldOfScience">
        <language>en</language>
        <availableLanguages>de,en,es,fr,it,pl</availableLanguages>
        <code>/21/35/153/627</code>
        <title>parkinson</title>
        <displayCode>/medical and health sciences/basic medicine/neurology/parkinson</displayCode>
      </category>
      <category classification="euroSciVoc" type="isInFieldOfScience">
        <language>en</language>
        <availableLanguages>de,en,es,fr,it,pl</availableLanguages>
        <code>/29/91/523</code>
        <title>business and management</title>
        <displayCode>/social sciences/economics and business/business and management</displayCode>
      </category>
      <category classification="policyPriorities" type="marker" weight="0">
        <language>en</language>
        <availableLanguages>de,en,es,fr,it,pl</availableLanguages>
        <code>/digitalAgenda</code>
        <title>Digital agenda</title>
        <description>This tracker monitors Horizon Europe’s financial contribution to the development of digital technologies and the digitisation of the economy and society (known as ‘Digital transition’).</description>
        <displayCode>/Digital agenda</displayCode>
      </category>
      <category classification="policyPriorities" type="marker" weight="0">
        <language>en</language>
        <availableLanguages>de,en,es,fr,it,pl</availableLanguages>
        <code>/cleanAir</code>
        <title>Clean air</title>
        <description>This tracker monitors the Horizon Europe’s financial contribution to the clean air policy (National Emission Ceiling Directive) aiming to improve ambient air quality and tackle air pollution, to protect the environment and human health.</description>
        <displayCode>/Clean air</displayCode>
      </category>
      <category classification="policyPriorities" type="marker" weight="0">
        <language>en</language>
        <availableLanguages>de,en,es,fr,it,pl</availableLanguages>
        <code>/ai</code>
        <title>Artificial intelligence</title>
        <description>This tracker monitors Horizon Europe’s financial contribution to the development and deployment of AI-based technologies and solutions. Projects that develop AI-tools as part of their research method are included</description>
        <displayCode>/Artificial intelligence</displayCode>
      </category>
      <category classification="policyPriorities" type="marker" weight="0">
        <language>en</language>
        <availableLanguages>de,en,es,fr,it,pl</availableLanguages>
        <code>/climate</code>
        <title>Climate action</title>
        <description>This tracker monitors the Horizon Europe’s financial contribution to both mitigating climate change (e.g., contributions to the reduction of greenhouse gas emissions) and adapting to climate change by building resilience (e.g., regarding floods, droughts, spatial planning and better governance, adaptation to changing climate in value chains, etc.).</description>
        <displayCode>/Climate action</displayCode>
      </category>
      <category classification="policyPriorities" type="marker" weight="0">
        <language>en</language>
        <availableLanguages>de,en,es,fr,it,pl</availableLanguages>
        <code>/biodiversity</code>
        <title>Biodiversity</title>
        <description>This tracker monitors the Horizon Europe’s financial contribution to Europe’s biodiversity’s path to recovery including species protection, ecosystem conservation, and habitat rehabilitation, all essential for resilience in climate adaptation and addressing ecosystem services but also environmental crime and the health-environment connection.</description>
        <displayCode>/Biodiversity</displayCode>
      </category>
      <category classification="projectFundingSchemeCategory" type="relatedProjectFundingSchemeCategory">
        <language>en</language>
        <availableLanguages>en</availableLanguages>
        <code>/HORIZON-CSA</code>
        <title>HORIZON Coordination and Support Actions</title>
        <description>HORIZON Coordination and Support Actions</description>
        <displayCode>/HORIZON Coordination and Support Actions</displayCode>
      </category>
      <category classification="source" type="isProvidedBy">
        <language>en</language>
        <availableLanguages>de,en,es,fr,it,pl</availableLanguages>
        <code>/corda</code>
        <title>CORDA</title>
        <description>RTD research data warehouse</description>
        <displayCode>/CORDA</displayCode>
      </category>
    </categories>
  </relations>
</project>